SAN DIEGO, Feb. 23, 2015 (GLOBE NEWSWIRE) -- ICON Vapor, Inc. (OTCPK:ICNV) is pleased to announce a Sales and Broker agreement signed with Impact Sales & Marketing, LLC. ("ISM")
Founded in 2004, Impact Sales and Marketing, LLC., calls on over 185 wholesalers, retailers, and distributors in a wide variety of markets covering; Food, Drug, Petrol and Convenience Stores. ISM employs professional in house sales staffs that manage this valuable retail space throughout Texas, Colorado, New Mexico, and Oklahoma.
"Impact Sales and Marketing is owned and managed by Diane Drew whose company is one of the premier brokers in this dynamic region of the country, with Texas's vibrant economy at its core," stated ICON Vapor's CEO, Dan Balsiger. "We are extremely pleased to add ISM to our Sales and Brokerage Team and her organization will be a huge asset to our company as we continue to grow our reach and distribution." ICON Vapor's CEO went on to say "Impact Sales' reach is extremely broad covering a high level of retailers including; 7-11, Loves, Quick Trip, Circle-K, CST Brands and EZ-Mart which will help us in reaching our goal of developing the ICON Vapor name and products into a nationally recognized brand."
About ICON Vapor, Inc.:
Headquartered in San Diego, California, ICON Vapor, Inc. engages in the manufacture and distribution of Ultra Premium Vapor Products. The company offers a wide variety of Vapor Products, Vape Pens & E-Liquids that are made in the USA, all branded under the ICON Vapor Products line. For further information please contact the Company at: www.IconVapor.com
Safe Harbor Statement:
This press release may contain forward looking statements and or observations which are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues as well as any payment of dividends on our stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties include but not limited to information as contained within the Company's most current quarterly reports, annual reports, and or other such filings as may be accessed through the OTCBB website. Furthermore, the Company disclaims any intention or obligation to update or revise any such forward looking statements, whether as a result of new information, future events, or otherwise. We have incurred and will continue to incur significant expenses in our expansion of our existing as well as new product lines noting there is no assurance that we will generate enough revenues to offset those costs. Additional product offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the variables as associated with the general business channel we are operating in, the impact of which cannot be predicted at this time including risks as associated with our product and recent FDA pronouncements. Additionally, our 1-A registration statement will generate additional free trading shares to the marketplace at a pre-determined price which may impact our share pricing within the OTC marketplace in a manner that we cannot predict.